Related Experiment Video
Updated: May 15, 2026

Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
Processing-driven chemical transformations and pharmacological shifts in Panax notoginseng
Xuan Zeng1, Yuying Zheng2, Pan Chen3
1Department of Emergency, The First People's Hospital of Foshan (Foshan Hospital Affiliated to Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Foshan, Guangdong, 528000, China; Clinical Research Center, The First People's Hospital of Foshan (Foshan Hospital Affiliated to Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Foshan, Guangdong, 528000, China; Foshan Key Laboratory of Precision Therapy in Oncology and Neurology, Foshan, Guangdong, 528000, China.
Ethnopharmacological Relevance:
The processing of Panax notoginseng (PN) is a quintessential example of the traditional Chinese medicine principle of "different uses for raw and processed products", embodied in the theory of "raw for dispersing while processed for tonifying". However, few studies are available summarizing the corresponding chemical transformations and pharmacological shifts.
Aim:
This review aims to synthesize current research to elucidate the processing-driven chemical transformations and pharmacological shifts in PN.
Methods:
Focused on the core topic of chemical transformations and pharmacological shifts in PN driven by processing, a systematic search of eligible literature published since 2015 was conducted across several databases, including Scopus, PubMed, Web of Science, the Chinese National Knowledge Infrastructure, the Chinese Biomedical Database, the WanFang Database, and the Chinese Science and Technology Journals Database.
Results:
Key findings indicate that heat-based processing significantly reduces hemostatic components like dencichine while converting native saponins (e.g., ginsenoside Rg1, Rb1, Rd, Re, notoginsenoside R1) into rare saponins (e.g., ginsenoside Rg3, Rg5, Rk1, Rk3, Rh4). This compositional remodeling underpins the efficacy transition that raw PN excels in hemostasis and blood activation, whereas the processed form exhibits enhanced blood-nourishing, immunomodulatory, and anti-tumor activities. However, critical gaps persist, including the lack of dedicated quality standards for processed products, non-standardized processing protocols reliant on empirical judgment, and a fragmented understanding of the systemic mechanisms linking compositional changes to holistic efficacy.
Conclusion:
This review summarizes critical advances in understanding the inherent chemical transformations and pharmacological shifts in PN driven by processing. To advance the field, future research must focus on processing standardization through objective chemical endpoints, establishing quality markers based on multiple rare saponins, investigating processing-chemistry-efficacy-mechanism relationships, and translating laboratory findings into clinical evidence. These further studies are essential for transforming traditional wisdom into precision science, ensuring clinical efficacy and facilitating the global recognition of PN.
Related Concept Videos
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Pharmacogenetics of Drug Metabolism: Overview
Prodrugs
Prodrugs help overcome...